Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Seattle WA, Sioux Falls SD, San Antonio TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06803680
Phase1, Recruiting
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
for
Hormone-receptor-positive Breast Cancer,
Location: Seattle WA, Iowa City IA, Houston TX
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06756932
Phase1, Recruiting
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Seattle WA, Portland OR, Palo Alto CA, Duarte CA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 18 - 66
Code: NCT06859424
Phase2, Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Get alerts for new trials in your area by subscribing now
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
for
Financial Hardship, Alzheimer's Disease (AD),
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT06922188
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Location: Seattle WA, Portland OR, Duarte CA, Dallas TX,
Sponsor: Eureka Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04864054
Phase1, Phase2, Recruiting
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Seattle WA, Vancouver, Calgary, Salt Lake City UT,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
Collection of Tissue Samples for Cancer Research
for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Seattle WA, Iowa City IA, St Louis MO, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT00900198
Recruiting
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma
Location: Seattle WA, Duarte CA, Dallas TX, Chicago IL,
Sponsor: Iterion Therapeutics
Sex: All
Age: 18+
Code: NCT05797805
Phase1, Phase2, Recruiting
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
for
Non-Malignant Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 49
Code: NCT04083183
Phase1, Phase2, Recruiting
Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
for
Cytokine Release Syndrome
Location: Seattle WA, Orange CA, Pittsburgh PA, Augusta GA,
Sponsor: CytoAgents, Inc.
Sex: All
Age: 18+
Code: NCT05905328
Phase1, Phase2, Recruiting
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Portland OR, Milwaukee WI, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06855771
Phase2, Recruiting
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia